Researchers at Generate Biomedicines used Claude to help redesign the signaling component inside engineered cancer-fighting immune cells. One design was about 70% shorter and performed better in lab tests. Turning that laboratory advantage into a useful treatment remains the next challenge. #Claude #Biotechnology #CancerResearch